Silynxcom VP reports 150,000 share options

Silynxcom Ltd. director and officer Klein Gal Nir filed an initial ownership report showing a holding of share options over 150,000 ordinary shares.

Rhea-AI Filing Summary

Silynxcom Ltd. director and officer Klein Gal Nir filed an initial ownership report showing a holding of share options over 150,000 ordinary shares. These options have an exercise price of $1.07 per share and expire on December 30, 2035. They were granted on December 30, 2025 and vest in equal quarterly installments over three years beginning on March 31, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Klein Gal Nir

Role VP Marketing & Israel Sales

Type	Security	Shares	Price	Value
holding	Share options (right to buy)	--	--	--

Holdings After Transaction: Share options (right to buy) — 150,000 contracts (Direct)

Footnotes (1)

1. F1. The options were granted on December 30, 2025, and vest in equal quarterly installments over a three-year period beginning on March 31, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Silynxcom (SYNX) Form 3 filing by Klein Gal Nir report?

The Form 3 reports Klein Gal Nir’s initial ownership of options over 150,000 Silynxcom ordinary shares. It records these as derivative securities with a fixed exercise price, vesting schedule, and expiration date as part of his role with the company.

How many Silynxcom (SYNX) share options does Klein Gal Nir hold?

Klein Gal Nir holds options linked to 150,000 Silynxcom ordinary shares. These options provide the right to buy shares at a preset price, subject to the vesting conditions and the expiration date disclosed in the filing and footnote.

What is the exercise price and expiration date of Klein Gal Nir’s Silynxcom options?

The options have an exercise price of $1.07 per share and expire on December 30, 2035. This means they can be exercised at that price any time after vesting and before the stated expiration date, under the plan terms.

When do Klein Gal Nir’s Silynxcom (SYNX) options vest?

The options were granted on December 30, 2025 and vest in equal quarterly installments over three years starting on March 31, 2026. This staged vesting means portions become exercisable every quarter during the three-year period.

What is Klein Gal Nir’s role at Silynxcom (SYNX) according to the Form 3?

Klein Gal Nir is identified as both a director and an officer, serving as VP Marketing & Israel Sales. The Form 3 links these positions with his reported derivative holdings, reflecting equity-based compensation aligned with his leadership responsibilities.

Does the Silynxcom Form 3 show any stock purchases or sales by Klein Gal Nir?

The Form 3 presents an initial holding entry for share options rather than a purchase or sale transaction. It lists derivative options over 150,000 shares with specific grant, vesting, and expiration terms, without recording open-market buying or selling activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 06:15 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Klein Gal Nir

(Last) (First) (Middle)

7 GIBOREI ISRAEL

(Street)

NETANYA 4250407

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Silynxcom Ltd. [ SYNX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Marketing & Israel Sales

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share options (right to buy)(1)	03/31/2026	12/30/2035	Ordinary Shares, no par value per share	150,000	$1.07	D

Explanation of Responses:

1. The options were granted on December 30, 2025, and vest in equal quarterly installments over a three-year period beginning on March 31, 2026.

	/s/ Gal Nir Klein	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)